Latest Annuities News

Clean TeQ Water Limited reported strong operational progress in Q3 FY25, advancing key projects like PHOSPHIX and Heathgate uranium plant commissioning, while improving cash receipts and securing major contracts.

SRG Global has reported a record first half for FY25, posting a 21% revenue increase and upgrading its full-year profit guidance, driven by strong cash flow and successful integration of the Diona acquisition.

SRG Global has delivered a record first half in FY25, posting strong revenue and profit growth alongside a successful acquisition integration that boosts its water security and energy transition capabilities.

Challenger Limited reported a robust first half of FY25 with a 12% rise in normalized NPAT and a 12% increase in its interim dividend, driven by strong annuity sales and strategic technology investments.

Challenger Limited has reported a robust first half of FY25, with a 12% increase in normalized NPAT and significant strides in annuity sales and technology modernization, positioning the company for sustained growth.

Challenger Limited posted a robust first half of FY25, with normalised net profit after tax rising 12% to $225 million, underpinned by strong Life and Funds Management segments despite softer annuity sales. The company maintains a confident outlook for FY25, forecasting further profit growth.

Challenger Limited reported a robust 12% increase in normalized NPAT to $225 million for 1H25, underpinned by strong earnings, dividend growth, and strategic investments in technology and distribution channels.

Challenger Limited reported a robust first half of FY25, delivering a 12% rise in normalised net profit after tax and record annuity sales, underpinned by strategic technology investments and longer tenor products.

Challenger Limited reported a robust 28% increase in statutory net profit after tax to $72 million for 1H25, alongside a 12% rise in normalised net profit and a higher interim dividend. Despite a 12% decline in total life sales, the company’s assets under management grew 12% to $131 billion, reflecting strong operational momentum.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

Macquarie Group’s 3Q25 trading update reveals strong growth in its annuity-style businesses, while markets-facing segments face pressure from subdued commodity markets, resulting in a mixed financial performance for the year to date.

Macquarie Group's 3Q25 trading update reveals strong growth in annuity-style businesses offset by a significant decline in markets-facing segments due to subdued commodity markets. The group's capital position remains robust, comfortably exceeding regulatory requirements.